Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088892530> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2088892530 abstract "After the safety issues raised by the Salmeterol Multicenter Asthma Research Trial, concerns persist about the safety of agents that cause prolonged β-adrenoceptor stimulation in asthmatic patients. We therefore decided to revisit and review the use of continuous subcutaneous infusions of terbutaline (CSIT)-a treatment often reserved for those with severe and refractory disease.Original studies from the 1980s included 26 patients and showed that CSIT was well tolerated with predominately cutaneous side effects despite maintaining very high serum levels of terbutaline. CSIT led to improved outcomes in approximately 75% of patients which included rises in lowest daily peak expiratory flow rate (PEFR), diminution in diurnal variation, reduction in other medication requirements, and subjective opinion of symptoms. Almost all patients demonstrating an improvement had a wide variation in their pretreatment PEFRs. However, in a retrospective follow-up of 42 patients, the only outcome to be significantly improved by CSIT was that of mean hospital admissions (p = .031). CSIT is theorized to stimulate a discrete set of β-receptors not accessible by the inhaled route as further increases in Forced expiratory volume in one second (FEV(1)) occur with concurrent nebulized therapy.Although some findings are encouraging, they are drawn from small observational studies done at a time when the standard management of asthma was quite different from today. No randomized controlled trials exist for the use of CSIT, which remains off-license for the treatment of asthma in the United Kingdom. Clearly, prospective well-powered studies are required to fully ascertain its potential benefits and safety profile-something that is unlikely to occur given that the use of CSIT remains low and appears to be declining." @default.
- W2088892530 created "2016-06-24" @default.
- W2088892530 creator A5024328122 @default.
- W2088892530 creator A5087954482 @default.
- W2088892530 date "2011-09-26" @default.
- W2088892530 modified "2023-10-17" @default.
- W2088892530 title "Continuous Infusions of Terbutaline in Asthma – A Review" @default.
- W2088892530 cites W1964592917 @default.
- W2088892530 cites W1982732664 @default.
- W2088892530 cites W1985021264 @default.
- W2088892530 cites W2007202893 @default.
- W2088892530 cites W2017060073 @default.
- W2088892530 cites W2019363399 @default.
- W2088892530 cites W2022296359 @default.
- W2088892530 cites W2039593801 @default.
- W2088892530 cites W2090578166 @default.
- W2088892530 cites W2093092614 @default.
- W2088892530 cites W2104543948 @default.
- W2088892530 cites W2114924619 @default.
- W2088892530 cites W2117575445 @default.
- W2088892530 cites W2143172275 @default.
- W2088892530 cites W2163441905 @default.
- W2088892530 cites W2255090123 @default.
- W2088892530 cites W2168501375 @default.
- W2088892530 doi "https://doi.org/10.3109/02770903.2011.613509" @default.
- W2088892530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21942352" @default.
- W2088892530 hasPublicationYear "2011" @default.
- W2088892530 type Work @default.
- W2088892530 sameAs 2088892530 @default.
- W2088892530 citedByCount "4" @default.
- W2088892530 countsByYear W20888925302015 @default.
- W2088892530 countsByYear W20888925302016 @default.
- W2088892530 countsByYear W20888925302018 @default.
- W2088892530 countsByYear W20888925302019 @default.
- W2088892530 crossrefType "journal-article" @default.
- W2088892530 hasAuthorship W2088892530A5024328122 @default.
- W2088892530 hasAuthorship W2088892530A5087954482 @default.
- W2088892530 hasConcept C126322002 @default.
- W2088892530 hasConcept C168563851 @default.
- W2088892530 hasConcept C177713679 @default.
- W2088892530 hasConcept C187212893 @default.
- W2088892530 hasConcept C197934379 @default.
- W2088892530 hasConcept C23131810 @default.
- W2088892530 hasConcept C2776042228 @default.
- W2088892530 hasConcept C2776719499 @default.
- W2088892530 hasConcept C2780252434 @default.
- W2088892530 hasConcept C2781018748 @default.
- W2088892530 hasConcept C42219234 @default.
- W2088892530 hasConcept C71924100 @default.
- W2088892530 hasConceptScore W2088892530C126322002 @default.
- W2088892530 hasConceptScore W2088892530C168563851 @default.
- W2088892530 hasConceptScore W2088892530C177713679 @default.
- W2088892530 hasConceptScore W2088892530C187212893 @default.
- W2088892530 hasConceptScore W2088892530C197934379 @default.
- W2088892530 hasConceptScore W2088892530C23131810 @default.
- W2088892530 hasConceptScore W2088892530C2776042228 @default.
- W2088892530 hasConceptScore W2088892530C2776719499 @default.
- W2088892530 hasConceptScore W2088892530C2780252434 @default.
- W2088892530 hasConceptScore W2088892530C2781018748 @default.
- W2088892530 hasConceptScore W2088892530C42219234 @default.
- W2088892530 hasConceptScore W2088892530C71924100 @default.
- W2088892530 hasLocation W20888925301 @default.
- W2088892530 hasLocation W20888925302 @default.
- W2088892530 hasOpenAccess W2088892530 @default.
- W2088892530 hasPrimaryLocation W20888925301 @default.
- W2088892530 hasRelatedWork W1963936757 @default.
- W2088892530 hasRelatedWork W1981325629 @default.
- W2088892530 hasRelatedWork W1990002876 @default.
- W2088892530 hasRelatedWork W1992276444 @default.
- W2088892530 hasRelatedWork W2085152092 @default.
- W2088892530 hasRelatedWork W2087033112 @default.
- W2088892530 hasRelatedWork W2087666617 @default.
- W2088892530 hasRelatedWork W2210176610 @default.
- W2088892530 hasRelatedWork W2402183361 @default.
- W2088892530 hasRelatedWork W4232198835 @default.
- W2088892530 isParatext "false" @default.
- W2088892530 isRetracted "false" @default.
- W2088892530 magId "2088892530" @default.
- W2088892530 workType "article" @default.